Melanoma: Adjuvant treatment of patients with Stage IIB, IIC, or III melanoma following complete resection research hub

Assessment of Pharmacokinetic Similarity of FYB206 in Comparison with Keytruda in Resected Stage II or Stage III Melanoma Patients

This study tests a new medicine called FYB206 for adults who have had advanced skin cancer (melanoma) removed by surgery. Researchers want to check if FYB206 behaves in the body in the exact same way as Keytruda, an approved immunotherapy drug used to help stop cancer returning.